Progress in the lung cancer diagnostic and treatment landscape is advancing at unprecedented rates. Even so, healthcare practice and policies and many clinical trials and therapies are developed without the direct input of the patients who are intended to be served.
LUNGevity’s Patient-Focused Research Center (Patient FoRCe) is a bridge to connect the patient voice with healthcare professionals, regulators, policymakers, and developers of drugs to ensure that their voices are heard and incorporated into decisions.
Patient FoRCe is changing the paradigm in lung cancer from assumptions being made about patient preferences to evidence-based conclusions about what patients value.
Through qualitative and quantitative research, LUNGevity’s Patient FoRCe seeks to uncover gaps in information, misperceptions about patient attitudes, and areas of unmet need. We then incorporate lung cancer patients’ preferences and experiences into healthcare delivery reform and the development of policy, treatments, and research protocols that affect lung cancer patients.
Our projects are uniquely patient-focused, involve multiple stakeholders, and fall into three broad categories: